510(k) K180296
K180296 is an FDA 510(k) premarket notification submitted by Alere Technologies AS for the device "Afinion HbA1c Dx". The FDA issued a decision of Substantially Equivalent on May 7, 2018. The device falls under product code PDJ (Hemoglobin A1c Test System), a Class II device regulated under 21 CFR 862.1373. Alere Technologies AS has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 7, 2018
- Date Received
- Feb 2, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Hemoglobin A1c Test System
- Device Class
- Class II
- Regulation Number
- 862.1373
- Review Panel
- CH
- Submission Type
- 510(k)
Quantitative determination of Hemoglobin A1c to aid in the diagnosis of diabetes.
Need the full FDA record for Alere Technologies AS? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.